User profiles for "author:G P Comi"

Giacomo Pietro Comi

Professor of Neurology
Verified email at unimi.it
Cited by 37927

The role of mitochondria in neurodegenerative diseases: the lesson from Alzheimer's disease and Parkinson's disease

G Monzio Compagnoni, A Di Fonzo, S Corti… - Molecular …, 2020 - Springer
Although the pathogenesis of neurodegenerative diseases is still widely unclear, various
mechanisms have been proposed and several pieces of evidence are supportive for an …

[HTML][HTML] Neural stem cell transplantation for neurodegenerative diseases

R De Gioia, F Biella, G Citterio, F Rizzo, E Abati… - International journal of …, 2020 - mdpi.com
Neurodegenerative diseases are disabling and fatal neurological disorders that currently
lack effective treatment. Neural stem cell (NSC) transplantation has been studied as a …

Spinal muscular atrophy—recent therapeutic advances for an old challenge

I Faravelli, M Nizzardo, GP Comi, S Corti - Nature Reviews Neurology, 2015 - nature.com
In the past decade, improved understanding of spinal muscular atrophy (SMA)
aetiopathogenesis has brought us to a historical turning point: we are at the verge of …

Genome-wide association analyses identify new risk variants and the genetic architecture of amyotrophic lateral sclerosis

W Van Rheenen, A Shatunov, AM Dekker… - Nature …, 2016 - nature.com
To elucidate the genetic architecture of amyotrophic lateral sclerosis (ALS) and find
associated loci, we assembled a custom imputation reference panel from whole-genome …

Role of adenine nucleotide translocator 1 in mtDNA maintenance

J Kaukonen, JK Juselius, V Tiranti, A Kyttälä… - Science, 2000 - science.org
Autosomal dominant progressive external ophthalmoplegia is a rare human disease that
shows a Mendelian inheritance pattern, but is characterized by large-scale mitochondrial …

[PDF][PDF] Exome-wide rare variant analysis identifies TUBA4A mutations associated with familial ALS

BN Smith, N Ticozzi, C Fallini, AS Gkazi, S Topp… - Neuron, 2014 - cell.com
Exome sequencing is an effective strategy for identifying human disease genes. However,
this methodology is difficult in late-onset diseases where limited availability of DNA from …

Ataluren in patients with nonsense mutation Duchenne muscular dystrophy (ACT DMD): a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial

CM McDonald, C Campbell, RE Torricelli, RS Finkel… - The Lancet, 2017 - thelancet.com
Background Duchenne muscular dystrophy (DMD) is a severe, progressive, and rare
neuromuscular, X-linked recessive disease. Dystrophin deficiency is the underlying cause of …

Ataluren treatment of patients with nonsense mutation dystrophinopathy

K Bushby, R Finkel, B Wong, R Barohn… - Muscle & …, 2014 - Wiley Online Library
Introduction: Dystrophinopathy is a rare, severe muscle disorder, and nonsense mutations
are found in 13% of cases. Ataluren was developed to enable ribosomal readthrough of …

Identification of a primitive brain–derived neural stem cell population based on aldehyde dehydrogenase activity

S Corti, F Locatelli, D Papadimitriou, C Donadoni… - Stem …, 2006 - academic.oup.com
Stem cells are undifferentiated cells defined by their ability to self-renew and differentiate to
progenitors and terminally differentiated cells. Stem cells have been isolated from almost all …

Autologous transplantation of muscle-derived CD133+ stem cells in Duchenne muscle patients

Y Torrente, M Belicchi, C Marchesi… - Cell …, 2007 - journals.sagepub.com
Duchenne muscular dystrophy (DMD) is a lethal X-linked recessive muscle disease due to
defect on the gene encoding dystrophin. The lack of a functional dystrophin in muscles …